Literature DB >> 29763382

KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.

Joo-Young Kang1, Ji-Young Kim1, Kee-Beom Kim1, Jin Woo Park1, Hana Cho1, Ja Young Hahm1, Yun-Cheol Chae1, Daehwan Kim1, Hyun Kook2,3, Sangmyeong Rhee1, Nam-Chul Ha4, Sang-Beom Seo1.   

Abstract

The methylation of histone H3 lysine 79 (H3K79) is an active chromatin marker and is prominent in actively transcribed regions of the genome; however, demethylase of H3K79 remains unknown despite intensive research. Here, we show that KDM2B, also known as FBXL10 and a member of the Jumonji C family of proteins known for its histone H3K36 demethylase activity, is a di- and trimethyl H3K79 demethylase. We demonstrate that KDM2B induces transcriptional repression of HOXA7 and MEIS1 via occupancy of promoters and demethylation of H3K79. Furthermore, genome-wide analysis suggests that H3K79 methylation levels increase when KDM2B is depleted, which indicates that KDM2B functions as an H3K79 demethylase in vivo. Finally, stable KDM2B-knockdown cell lines exhibit displacement of NAD+-dependent deacetylase sirtuin-1 (SIRT1) from chromatin, with concomitant increases in H3K79 methylation and H4K16 acetylation. Our findings identify KDM2B as an H3K79 demethylase and link its function to transcriptional repression via SIRT1-mediated chromatin silencing.-Kang, J.-Y., Kim, J.-Y., Kim, K.-B., Park, J. W., Cho, H., Hahm, J. Y., Chae, Y.-C., Kim, D., Kook, H., Rhee, S., Ha, N.-C., Seo, S.-B. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.

Entities:  

Keywords:  H3K79 methylation; SIRT1; histone demethylase; transcription

Mesh:

Substances:

Year:  2018        PMID: 29763382     DOI: 10.1096/fj.201800242R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  23 in total

1.  Nucleosome Turnover Regulates Histone Methylation Patterns over the Genome.

Authors:  Emma J Chory; Joseph P Calarco; Nathaniel A Hathaway; Oliver Bell; Dana S Neel; Gerald R Crabtree
Journal:  Mol Cell       Date:  2018-11-21       Impact factor: 17.970

Review 2.  Updates on the epigenetic roles of sirtuins.

Authors:  Tatsiana Kosciuk; Miao Wang; Jun Young Hong; Hening Lin
Journal:  Curr Opin Chem Biol       Date:  2019-03-12       Impact factor: 8.822

Review 3.  Histone modification in podocyte injury of diabetic nephropathy.

Authors:  Simeng Wang; Xinyu Zhang; Qinglian Wang; Rong Wang
Journal:  J Mol Med (Berl)       Date:  2022-08-30       Impact factor: 5.606

Review 4.  Histone Lysine Methylation Modification and Its Role in Vascular Calcification.

Authors:  Ye-Chi Cao; Su-Kang Shan; Bei Guo; Chang-Chun Li; Fu-Xing-Zi Li; Ming-Hui Zheng; Qiu-Shuang Xu; Yi Wang; Li-Min Lei; Ke-Xin Tang; Wen-Lu Ou-Yang; Jia-Yue Duan; Yun-Yun Wu; Muhammad Hasnain Ehsan Ullah; Zhi-Ang Zhou; Feng Xu; Xiao Lin; Feng Wu; Xiao-Bo Liao; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

Review 5.  The Chromatin Landscape Channels DNA Double-Strand Breaks to Distinct Repair Pathways.

Authors:  Zulong Chen; Jessica K Tyler
Journal:  Front Cell Dev Biol       Date:  2022-06-08

6.  DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A.

Authors:  Kelly E Leon; Raquel Buj; Elizabeth Lesko; Erika S Dahl; Chi-Wei Chen; Naveen Kumar Tangudu; Yuka Imamura-Kawasawa; Andrew V Kossenkov; Ryan P Hobbs; Katherine M Aird
Journal:  J Cell Biol       Date:  2021-05-26       Impact factor: 8.077

7.  Histone lysine demethylase 3B (KDM3B) regulates the propagation of autophagy via transcriptional activation of autophagy-related genes.

Authors:  Hyeonsoo Jung; Sang-Beom Seo
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

Review 8.  Tackling malignant melanoma epigenetically: histone lysine methylation.

Authors:  Elias Orouji; Jochen Utikal
Journal:  Clin Epigenetics       Date:  2018-11-22       Impact factor: 6.551

9.  DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation.

Authors:  Laura Godfrey; Nicholas T Crump; Ross Thorne; I-Jun Lau; Emmanouela Repapi; Dimitra Dimou; Alastair L Smith; Joe R Harman; Jelena M Telenius; A Marieke Oudelaar; Damien J Downes; Paresh Vyas; Jim R Hughes; Thomas A Milne
Journal:  Nat Commun       Date:  2019-06-26       Impact factor: 14.919

10.  SIRT1 inhibits hepatocellular carcinoma metastasis by promoting M1 macrophage polarization via NF-κB pathway.

Authors:  Bei Zhou; Yun Yang; Cuiping Li
Journal:  Onco Targets Ther       Date:  2019-04-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.